BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 15576304)

  • 21. The apoB/apoA-I ratio is better than the cholesterol ratios to estimate the balance between plasma proatherogenic and antiatherogenic lipoproteins and to predict coronary risk.
    Walldius G; Jungner I; Aastveit AH; Holme I; Furberg CD; Sniderman AD
    Clin Chem Lab Med; 2004; 42(12):1355-63. PubMed ID: 15576296
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Association of coronary heart disease with serum lipid and apolipoprotein concentrations in long-term diabetes. Results of the Erfurt study.
    Schauer UJ; Pissarek D; Panzram G
    Acta Diabetol Lat; 1989; 26(1):35-42. PubMed ID: 2501960
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lipoprotein(a) levels are increased in healthy young subjects with parental history of premature myocardial infarction.
    Gaeta G; Cuomo S; Capozzi G; Foglia MC; Barra S; Madrid A; Stornaiuolo V; Trevisan M
    Nutr Metab Cardiovasc Dis; 2008 Sep; 18(7):492-6. PubMed ID: 17962002
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Fractional esterification rate of HDL particles in patients with type 2 diabetes. Relation to coronary heart disease risk factors.
    Tan MH; Loh KC; Dobiasova M; Frohlich JJ
    Diabetes Care; 1998 Jan; 21(1):139-42. PubMed ID: 9538985
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Apolipoprotein B and A-I distribution in Mexican urban adults: results of a nationwide survey.
    Valles V; Aguilar-Salinas CA; Gómez-Pérez FJ; Rojas R; Franco A; Olaiz G; Rull JA; Sepulveda J
    Metabolism; 2002 May; 51(5):560-8. PubMed ID: 11979386
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [An experience of lipoprotein (a) dosage in a Moroccan population of 184 subjects].
    Fellat S; Lahfidi K; Sraïri JE; el Haïtem N; Mesbahi R; Ghanam R; Benomar M
    Arch Mal Coeur Vaiss; 1997 Oct; 90(10):1371-6. PubMed ID: 9539837
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Genome-wide linkage analysis reveals evidence of multiple regions that influence variation in plasma lipid and apolipoprotein levels associated with risk of coronary heart disease.
    Klos KL; Kardia SL; Ferrell RE; Turner ST; Boerwinkle E; Sing CF
    Arterioscler Thromb Vasc Biol; 2001 Jun; 21(6):971-8. PubMed ID: 11397706
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Apolipoprotein(a) phenotypes, Lp(a) concentration and plasma lipid levels in relation to coronary heart disease in a Chinese population: evidence for the role of the apo(a) gene in coronary heart disease.
    Sandholzer C; Boerwinkle E; Saha N; Tong MC; Utermann G
    J Clin Invest; 1992 Mar; 89(3):1040-6. PubMed ID: 1541665
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Factors associated with low and elevated plasma high density lipoprotein cholesterol and apolipoprotein A-I levels in the Framingham Offspring Study.
    Schaefer EJ; Lamon-Fava S; Ordovas JM; Cohn SD; Schaefer MM; Castelli WP; Wilson PW
    J Lipid Res; 1994 May; 35(5):871-82. PubMed ID: 8071609
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A prospective study of cholesterol, apolipoproteins, and the risk of myocardial infarction.
    Stampfer MJ; Sacks FM; Salvini S; Willett WC; Hennekens CH
    N Engl J Med; 1991 Aug; 325(6):373-81. PubMed ID: 2062328
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Role of lipid, apolipoprotein levels and apolipoprotein E genotype in young Italian patients with myocardial infarction.
    Scaglione L; Bergerone S; Gambino R; Imazio M; Macchia G; Cravetto A; Gaschino G; Baralis G; Rosettani E; Pagano G; Cassader M
    Nutr Metab Cardiovasc Dis; 1999 Jun; 9(3):118-24. PubMed ID: 10464784
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Conventional lipid profile and lipoprotein(a) concentrations in treated patients with rheumatoid arthritis.
    García-Gómez C; Nolla JM; Valverde J; Gómez-Gerique JA; Castro MJ; Pintó X
    J Rheumatol; 2009 Jul; 36(7):1365-70. PubMed ID: 19369465
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of children and coronary heart disease patients with low high density lipoprotein cholesterol levels.
    Ohta T; Saku K; Nakamura R; Maung KK; Matsuda I
    Atherosclerosis; 1998 Apr; 137(2):321-8. PubMed ID: 9622275
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Influence of smoking, body fat distribution, and alcohol consumption on serum lipids, lipoproteins, and apolipoproteins in early postmenopausal women.
    Haarbo J; Hassager C; Schlemmer A; Christiansen C
    Atherosclerosis; 1990 Oct; 84(2-3):239-44. PubMed ID: 2282102
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lipid results of partial ileal bypass in patients with heterozygous, type II-A hyperlipoproteinemia. Program on the Surgical Control of the Hyperlipidemias.
    Campos CT; Matts JP; Fitch LL; Speech JC; Long JM; Buchwald H
    Surgery; 1990 Oct; 108(4):601-10; discussion 610-1. PubMed ID: 2120785
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of chronic alcohol consumption on lipid levels, inflammatory and haemostatic factors in the general population: the 'ATTICA' Study.
    Chrysohoou C; Panagiotakos DB; Pitsavos C; Skoumas J; Toutouza M; Papaioannou I; Toutouzas PK; Stefanadis C
    Eur J Cardiovasc Prev Rehabil; 2003 Oct; 10(5):355-61. PubMed ID: 14663297
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Residual dyslipidemia according to low-density lipoprotein cholesterol, non-high-density lipoprotein cholesterol, and apolipoprotein B among statin-treated US adults: National Health and Nutrition Examination Survey 2009-2010.
    Wong ND; Chuang J; Zhao Y; Rosenblit PD
    J Clin Lipidol; 2015; 9(4):525-32. PubMed ID: 26228670
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Moderate hyperalphalipoproteinaemia in a Brazilian population is related to lipoprotein lipase activity, apolipoprotein A-I concentration, age and body mass index.
    Alarcon SB; Oliveira HC; Harada LM; Nunes VS; Kaplan D; Quintão EC; de Faria EC
    Clin Sci (Lond); 2004 Jan; 106(1):11-7. PubMed ID: 12889988
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lipid parameters, lipid lowering drugs and the risk of venous thromboembolism.
    Delluc A; Malécot JM; Kerspern H; Nowak E; Carre JL; Mottier D; Le Gal G; Lacut K
    Atherosclerosis; 2012 Jan; 220(1):184-8. PubMed ID: 22035572
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lipoprotein and apolipoprotein levels in angiographically defined coronary atherosclerosis.
    Schmidt SB; Wasserman AG; Muesing RA; Schlesselman SE; Larosa JC; Ross AM
    Am J Cardiol; 1985 Jun; 55(13 Pt 1):1459-62. PubMed ID: 3923814
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.